Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Claudio Jommi

Showing results (1-10 of 84) with videos related to

Pageof 9
Sort By:
Global & Regional Health Technology Assessment|October 1, 2025
Claudio Jommi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 24, 2024
Value Attribution for Combination Treatments: Two Potential Solutions for an Insoluble ProblemOriana Ciani, Claudio Jommi
Medicina (Kaunas, Lithuania)|June 27, 2025
Obesity in Italy: An Empirical Analysis of Healthcare Consumption, Quality of Life and ComorbiditiesElenka Brenna, Claudio Jommi
Drug Design, Development and Therapy|November 25, 2014
The role of health technology assessment bodies in shaping drug developmentOriana Ciani, Claudio Jommi
Pharmacoeconomics - Open|February 10, 2023
The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal ConsistencyClaudio Jommi, Carlotta Galeone
Health Policy (Amsterdam, Netherlands)|July 11, 2006
Public administration and R&D localisation by pharmaceutical and biotech companies: a theoretical framework and the Italian case-studyClaudio Jommi, Silvia Paruzzolo
Health Policy (Amsterdam, Netherlands)|February 28, 2012
Stakeholders involvement by HTA Organisations: why is so different?Marianna Cavazza, Claudio Jommi
Pharmacoeconomics|December 20, 2007
The last decade of Italian pharmaceutical policy: instability or consolidation?Giovanni Fattore, Claudio Jommi
Frontiers in Pharmacology|May 21, 2024
Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in ItalyMatteo Bolcato, Claudio Jommi
Plos Neglected Tropical Diseases|September 5, 2014
Current pipelines for neglected diseasesPaolo di Procolo, Claudio Jommi
Pageof 9

Showing results (1-10 of 84) with videos related to

Sort By:
Pageof 9
Global & Regional Health Technology Assessment|October 1, 2025
Claudio Jommi
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 24, 2024
Value Attribution for Combination Treatments: Two Potential Solutions for an Insoluble ProblemOriana Ciani, Claudio Jommi
Medicina (Kaunas, Lithuania)|June 27, 2025
Obesity in Italy: An Empirical Analysis of Healthcare Consumption, Quality of Life and ComorbiditiesElenka Brenna, Claudio Jommi
Drug Design, Development and Therapy|November 25, 2014
The role of health technology assessment bodies in shaping drug developmentOriana Ciani, Claudio Jommi
Pharmacoeconomics - Open|February 10, 2023
The Evaluation of Drug Innovativeness in Italy: Key Determinants and Internal ConsistencyClaudio Jommi, Carlotta Galeone
Health Policy (Amsterdam, Netherlands)|July 11, 2006
Public administration and R&D localisation by pharmaceutical and biotech companies: a theoretical framework and the Italian case-studyClaudio Jommi, Silvia Paruzzolo
Health Policy (Amsterdam, Netherlands)|February 28, 2012
Stakeholders involvement by HTA Organisations: why is so different?Marianna Cavazza, Claudio Jommi
Pharmacoeconomics|December 20, 2007
The last decade of Italian pharmaceutical policy: instability or consolidation?Giovanni Fattore, Claudio Jommi
Frontiers in Pharmacology|May 21, 2024
Shortage of plasma-derived medicinal products: what is next? narrative literature review on its causes and counteracting policies in ItalyMatteo Bolcato, Claudio Jommi
Plos Neglected Tropical Diseases|September 5, 2014
Current pipelines for neglected diseasesPaolo di Procolo, Claudio Jommi
Pageof 9